These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 639231)

  • 1. Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy.
    Winkle RA
    Circulation; 1978 Jun; 57(6):1116-21. PubMed ID: 639231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term antiarrhythmic pharmaco-therapy guided by Holter monitoring in patients with malignant ventricular arrhythmias and ischemic heart disease.
    Trusz-Gluza M; Gasior Z; Wnuk-Wojnar AM; Filipecki A; Szydło K; Giec L
    Mater Med Pol; 1992; 24(4):229-32. PubMed ID: 1308049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in spontaneous variability of ventricular ectopic activity as a function of time in patients with chronic arrhythmias.
    Anastasiou-Nana MI; Menlove RL; Nanas JN; Anderson JL
    Circulation; 1988 Aug; 78(2):286-95. PubMed ID: 2456167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous variability and circadian distribution of ectopic activity in patients with malignant ventricular arrhythmia.
    Raeder EA; Hohnloser SH; Graboys TB; Podrid PJ; Lampert S; Lown B
    J Am Coll Cardiol; 1988 Sep; 12(3):656-61. PubMed ID: 3403822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
    Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
    G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of changes in the definition of ventricular tachycardia on the prevalence of complex ventricular ectopy.
    Insel J; Mirvis DM
    J Electrocardiol; 1989 Jan; 22(1):21-5. PubMed ID: 2921576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of antiarrhythmic drug efficacy in the treatment of ventricular arrhythmias.
    Morganroth J
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):669-73. PubMed ID: 2076377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous variability in ventricular ectopic activity during chronic antiarrhythmic therapy.
    Anderson JL; Anastasiou-Nana MI; Menlove RL; Moreno FL; Nanas JN; Barker AH
    Circulation; 1990 Sep; 82(3):830-40. PubMed ID: 1697514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
    Manz M; Mletzko R; Jung W; Lüderitz B
    Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N; Terry L; Murphy ML; Thompson CH; Doherty JE; Sakhaii M; Dinh H
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs.
    Graboys TB; Lown B; Podrid PJ; DeSilva R
    Am J Cardiol; 1982 Sep; 50(3):437-43. PubMed ID: 6180622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spontaneous variability of ventricular arrhythmias in follow-up of anti-arrhythmia therapy].
    Schmidt G; Barthel P; Ulm K; Goedel-Meinen L; Baedeker W
    Herz; 1990 Feb; 15(1):11-20. PubMed ID: 1690167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone for the treatment of refractory complex ventricular ectopic activity.
    Hammill SC; Sorenson PB; Wood DL; Sugrue DD; Osborn MJ; Gersh BJ; Holmes DR
    Mayo Clin Proc; 1986 Feb; 61(2):98-103. PubMed ID: 3945115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive diagnosis of ventricular arrhythmias by means of ambulatory-ECG monitoring.
    Candinas RA; Podrid PJ
    Herz; 1990 Feb; 15(1):1-10. PubMed ID: 2179087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent or complex ventricular ectopy in apparently healthy subjects: a clinical study of 25 cases.
    Kennedy HL; Underhill SJ
    Am J Cardiol; 1976 Aug; 38(2):141-8. PubMed ID: 952258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of ventricular arrhythmias by atenolol.
    Heng MK; Zimmer I
    Am Heart J; 1985 Jun; 109(6):1273-80. PubMed ID: 4003239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias.
    Facchini M; Bonazzi O; Priori SG; Varisco T; Zuanetti G; Schwartz PJ
    Eur Heart J; 1988 May; 9(5):462-70. PubMed ID: 3402461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
    Andresen D; von Leitner ER; Wegscheider K; Schröder R
    Z Kardiol; 1984 Aug; 73(8):492-7. PubMed ID: 6208699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.